QQQ   443.86 (-0.22%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
QQQ   443.86 (-0.22%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
QQQ   443.86 (-0.22%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
QQQ   443.86 (-0.22%)
AAPL   171.47 (-1.06%)
MSFT   420.25 (-0.28%)
META   487.97 (-1.19%)
GOOGL   150.76 (-0.07%)
AMZN   180.24 (+0.23%)
TSLA   176.61 (-1.79%)
NVDA   902.47 (+0.00%)
NIO   4.53 (-3.00%)
AMD   180.18 (+0.33%)
BABA   72.46 (+1.22%)
T   17.68 (+0.74%)
F   13.23 (+1.30%)
MU   117.55 (-1.33%)
CGC   9.10 (-4.71%)
GE   175.00 (-2.84%)
DIS   122.57 (+1.31%)
AMC   3.69 (-14.98%)
PFE   28.06 (+1.01%)
PYPL   67.21 (+0.96%)
XOM   116.07 (+0.96%)
NASDAQ:DH

Definitive Healthcare (DH) Stock Price, News & Analysis

$8.06
+0.15 (+1.90%)
(As of 01:57 PM ET)
Today's Range
$7.88
$8.13
50-Day Range
$7.61
$10.26
52-Week Range
$5.53
$12.45
Volume
287,322 shs
Average Volume
576,834 shs
Market Capitalization
$948.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.31

Definitive Healthcare MarketRank™ Stock Analysis

Analyst Rating
Hold
2.30 Rating Score
Upside/​Downside
40.4% Upside
$11.31 Price Target
Short Interest
Healthy
10.21% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.48mentions of Definitive Healthcare in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
18.18%
From $0.11 to $0.13 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.23 out of 5 stars

Medical Sector

171st out of 938 stocks

Health Information Services Industry

1st out of 3 stocks

DH stock logo

About Definitive Healthcare Stock (NASDAQ:DH)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.

DH Stock Price History

DH Stock News Headlines

AI Bubble Now at Critical Mass
Washington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.
Definitive Healthcare Corp Class A
DH Apr 2024 5.000 put
DH Jul 2024 5.000 put
AI Bubble Now at Critical Mass
Washington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.
What 4 Analyst Ratings Have To Say About Definitive Healthcare
Definitive Healthcare reports Q4 results
Earnings Outlook For Definitive Healthcare
DH Mar 2024 10.000 call
Definitive Healthcare just downgraded at Needham, here's why
See More Headlines
Receive DH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/28/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Prepackaged software
Sub-Industry
N/A
Fax
N/A
Employees
946
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.31
High Stock Price Target
$15.00
Low Stock Price Target
$9.50
Potential Upside/Downside
+43.0%
Consensus Rating
Hold
Rating Score (0-4)
2.30
Research Coverage
10 Analysts

Profitability

Net Income
$-202,390,000.00
Pretax Margin
-122.58%

Debt

Sales & Book Value

Annual Sales
$251.41 million
Cash Flow
$3.15 per share
Book Value
$10.31 per share

Miscellaneous

Free Float
99,747,000
Market Cap
$931.17 million
Optionable
Not Optionable
Beta
1.43
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Jason Ronald Krantz (Age 50)
    Founder, Executive Chairman & Interim CEO
    Comp: $820.92k
  • Mr. Jon Maack
    President
  • Mr. Richard Douglas BoothMr. Richard Douglas Booth (Age 55)
    Chief Financial Officer
    Comp: $562.44k
  • Ms. Kate Marie Shamsuddin Jensen (Age 38)
    Chief Product Officer
    Comp: $393.26k
  • Mr. Scott Oberlink
    Chief Technology Officer
  • Mr. Matt Ruderman
    Chief Legal Officer & Secretary
  • Mr. Craig Hazenfield
    Chief People Officer
  • Mr. Ram Sharma
    Executive Vice President of Life Sciences
  • Ms. Carrie Lazorchak
    Chief Revenue Officer

DH Stock Analysis - Frequently Asked Questions

Should I buy or sell Definitive Healthcare stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares.
View DH analyst ratings
or view top-rated stocks.

What is Definitive Healthcare's stock price target for 2024?

10 Wall Street analysts have issued 1-year price objectives for Definitive Healthcare's stock. Their DH share price targets range from $9.50 to $15.00. On average, they anticipate the company's share price to reach $11.31 in the next year. This suggests a possible upside of 40.4% from the stock's current price.
View analysts price targets for DH
or view top-rated stocks among Wall Street analysts.

How have DH shares performed in 2024?

Definitive Healthcare's stock was trading at $9.94 at the beginning of 2024. Since then, DH stock has decreased by 18.9% and is now trading at $8.06.
View the best growth stocks for 2024 here
.

Are investors shorting Definitive Healthcare?

Definitive Healthcare saw a drop in short interest in March. As of March 15th, there was short interest totaling 4,830,000 shares, a drop of 35.3% from the February 29th total of 7,470,000 shares. Based on an average daily trading volume, of 572,300 shares, the short-interest ratio is presently 8.4 days. Approximately 10.2% of the shares of the stock are short sold.
View Definitive Healthcare's Short Interest
.

When is Definitive Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our DH earnings forecast
.

How were Definitive Healthcare's earnings last quarter?

Definitive Healthcare Corp. (NASDAQ:DH) announced its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by $0.02. The firm earned $65.93 million during the quarter, compared to the consensus estimate of $66.01 million. Definitive Healthcare had a negative net margin of 80.40% and a positive trailing twelve-month return on equity of 0.43%.

What ETFs hold Definitive Healthcare's stock?
What guidance has Definitive Healthcare issued on next quarter's earnings?

Definitive Healthcare updated its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share guidance of 0.070-0.080 for the period, compared to the consensus EPS estimate of 0.070. The company issued revenue guidance of $63.0 million-$65.0 million, compared to the consensus revenue estimate of $65.7 million.

When did Definitive Healthcare IPO?

Definitive Healthcare (DH) raised $350 million in an IPO on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share.

Who are Definitive Healthcare's major shareholders?

Definitive Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (4.75%), Vanguard Group Inc. (3.84%), Vanguard Group Inc. (3.80%), Brown Advisory Inc. (3.38%), Massachusetts Financial Services Co. MA (2.98%) and Riverbridge Partners LLC (1.52%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc.
View institutional ownership trends
.

How do I buy shares of Definitive Healthcare?

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DH) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners